DekaBank Deutsche Girozentrale Has $8.60 Million Stock Holdings in Balchem Corporation (NASDAQ:BCPC)

DekaBank Deutsche Girozentrale raised its position in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 160.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 53,300 shares of the basic materials company's stock after buying an additional 32,800 shares during the quarter. DekaBank Deutsche Girozentrale owned 0.16% of Balchem worth $8,596,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Covestor Ltd increased its holdings in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after purchasing an additional 76 shares during the period. Federated Hermes Inc. acquired a new position in shares of Balchem in the 4th quarter valued at about $33,000. Versant Capital Management Inc increased its holdings in shares of Balchem by 534.2% in the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock valued at $40,000 after purchasing an additional 203 shares during the period. Huntington National Bank increased its holdings in shares of Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock valued at $108,000 after purchasing an additional 156 shares during the period. Finally, Atala Financial Inc acquired a new position in shares of Balchem in the 4th quarter valued at about $123,000. 87.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

BCPC has been the topic of a number of research reports. Wall Street Zen downgraded Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. HC Wainwright set a $180.00 price objective on Balchem and gave the stock a "buy" rating in a report on Monday, April 28th.

Balchem Stock Down 2.2%

BCPC traded down $3.49 during midday trading on Friday, hitting $158.44. 102,904 shares of the company's stock traded hands, compared to its average volume of 143,430. The company has a market cap of $5.17 billion, a PE ratio of 38.00, a price-to-earnings-growth ratio of 3.42 and a beta of 0.89. The stock's fifty day simple moving average is $163.82 and its 200-day simple moving average is $162.87. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.44 and a quick ratio of 1.40. Balchem Corporation has a one year low of $145.70 and a one year high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). The business had revenue of $250.52 million for the quarter, compared to the consensus estimate of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. Balchem's revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.03 EPS. As a group, equities analysts anticipate that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.